A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Early phase 1	2025-01-03		NCT06756321

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Nantong University	71
Shanghai First Song Biotechnology Co., LTD	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Nantong University	Nantong	China	33

Clinical trials